The Outlook for Transplantation of the Kidney in Man by Professor M F A Woodruff FRCS (Edinburgh) It has been said that some 250,000 people die each year as a result of renal insufficiency. It is impossible to estimate how many of these lives could be saved if the problems which at present limit the use of renal transplants were all solved, but the number is certainly considerable. These problems are of four kinds: (1) Technical, (2) immunological, (3) storage, and (4) ethical and legal.
TechnicalProblems
The technical problem of renal transplantation has largely been solved. The blood supply to the transplant must be re-established reasonably quicklypreferably within an hour unless special precautions are takenand provision made for the drainage and collection of urine. In practice this is best achieved by placing the transplant in an extraperitoneal position in the iliac fossa (the donor's left kidney in the recipient's right iliac fossa or vice versa). The usual procedure is to anastomose the artery of the transplant end-to-end to the divided internal iliac artery of the recipient, and the vein of the transplant endto-side to the external iliac vein of the recipient, but it is equally satisfactory to make both anastomoses end-to-side to the external iliac artery and vein respectively. Difficulty may be encountered if the transplant has two arteries, or if the recipient's arteries are atherosclerotic but, as Woodruff et al. (1961) have reported, it may still be possible to make a successful transplant. The ureter of the transplant may be anastomosed to the bladder or to the distal part of the ureter of the recipient. In either case it is desirable to sacrifice the distal two-thirds of the ureter of the transplant, because this not only reduces the risk of ischaemic necrosis of the distal part of the ureter but also, as Murnaghan (1960) has suggested, probably reduces the risk of reflux.
Transplantation of a kidney necessarily implies complete interruption of the nerve supply, but fortunately this does not seem to matter; thus a transplant may maintain life even if both the recipient's kidneys are removed at the time of (or just before) the transplantation, and within a few weeks its functional efficiency may be as good as that of a normal kidney. This is illustrated by cases in which a kidney has been transplanted from a healthy identical twin, for in this event the immunological problem does not arise. Most of these cases have been reported by Murray and his colleagues in Boston (Murray et al. 1958) . My own experience is limited to a single case (Woodruff et al. 1961 ). This has been fully reported elsewhere.
In summary, however, it may be said that the transplant shows normal clearance of creatinine and para-amino hippuric acid, and yields a normal intravenous pyelogram. It conserves sodium under conditions of sodium depletion, and is able to play its part in the regulation of acid-base equilibrium. Since the operation the recipient's blood urea nitrogen and blood pressure have fallen to normal, his retinal exudates and hemorrhages have disappeared, and he has returned to work.
The Immunological Problem It is now common knowledge that homografts as a general rule evoke a state of immunity in consequence of which they are destroyed within a few days or weeks. As evidence for this we may cite the fact, discovered by Gibson & Medawar (1943) and since confirmed by many observers, that a second graft from the same donor to the same recipient is normally destroyed more rapidly than the first, and the discovery of Mitchison (1954) that the state of increased reactivity induced by a homograft can, under certain conditions, be transferred passively by means of cells to a third party.
Some grafts used in surgery, such as massive bone grafts and segments of blood vessels, may be functionally effective even though they do not survive, because they provide a scaffolding for regenerating recipient tissues, but obviously this is not relevant to the subject of organ transplantation. There are, however, exceptions to the rule that homografts are rapidly destroyed, and these may be arranged under the following headings:
(1) Compatibility of -donor and recipient. (2) Special properties of certain tissues, notably cornea and cartilage. (3) Special properties of certain sites, notably the brain and the anterior chamber of the eye. (4) Constitutional abnormalities of the recipient, notably uremia, agammaglobulinmmia, Hodgkin's disease, and pregnancy. Compatibility of donor and recipient: Complete compatibility occurs when the donor and recipient are identical twins, and virtually complete com-patibility between members of the same sex can be achieved in experimental animals by brothersister mating over many generations. Nonidentical human twins may show a fairly high degree of compatibility, which is sometimes, as in the cases reported by Hamburger et al. (1959) and Merrill et al. (1960) , sufficient to permit successful renal transplantation after a dose of irradiation which would otherwise probably have been insufficient. Complete compatibility between nonidentical twins is, however, extremely unlikely except in the rare case when they happen to be blood chimeras (see Woodruff & Lennox 1959) .
It is important to note that, as Woodruff & Allan (1953) have reported, compatibility in respect of a large number of red cell antigens is not a sufficient condition (though it may well be necessary) for tissue compatibility in general.
Administration of corticosteroids or ACTH: It is. possible to double or treble the period of survival of various types of homograft by the administration of corticosteroids or ACTH (for review see Woodruff 1960, p 104 et seq.) . The effect varies in different species; administration of these substances is being tried clinically in combination with other procedures such as whole body irradiation. Their value, however, is still subjudice.
Induction of specific tolerance: The discovery of immunological tolerance by Medawar and his. colleagues (Billingham et al. 1953 (Billingham et al. , 1955 (Billingham et al. , 1956 provided a solution of the immunological homograft problem at an experimental level. Briefly they showed that if a mouse embryo in utero was injected with living cells from a mouse of a different strain it would under certain conditions, when it grew up, accept permanently grafts of skin from the original cell donor (or another animal of the same genetic constitution). It was shown subsequently in rats (Woodruff & Simpson 1955) , mice (Billingham & Brent 1957a ) and other species that tolerance could also be induced for a short time after birth, and an attempt was therefore made to induce tolerance to the tissues of the father in two human infants (Woodruff 1957) . Some degree of tolerance was in fact achieved, but these investigations were abandoned when it was. discovered by Billingham & Brent (1957b) that immature animals injected with foreign cells sometimes developed a condition which they called runt disease, characterized by diarrheea and wasting, and often culminating in death. This phenomenon occurs only when the injected cells are able to react immunologically against the recipient, and is an example of what is now termed graftversus-host disease.
There are grounds for believing that tolerance might be induced in adults simply by using a very much larger dose of foreign cells, but it seems doubtful whether enough viable cells could be obtained from one donor to achieve this in man. There are, however, two other possibilities. One is to combine the injection of donor cells in feasible dosage with whole body irradiation or administration of cytotoxic drugs. The other is to inject preparations of the transplantation antigens derived from donor tissues. In this way a much wider range of tissues could be utilized, and the risk of graft-versus-host disease could probably be completely eliminated.
Whole-body irradiation: It has been known for nearly half a century, from the work of Hektoen and Murphy, that irradiation with X-rays may impair an animal's capacity to react immunologically to bacterial antigens, heterologous erythrocytes and transplanted tumours. It seemed likely therefore that the survival of homografts of normal tissues could be prolonged by irradiating the recipient prior to transplantation. Proof of this was provided by Dempster et al. (1950) , who showed that skin homografts in rabbits given 250 rads whole body irradiation survived longer than in non-irradiated controls, but the longest survival was only twenty-four days.
Immunologically, it is probably easier to obtain long survival of homotransplants of whole organs by vascular anastomosis than of free homotransplants of skin, and probably also easier to obtain long-surviving organ transplants in man than, for example, in dogs. Moreover, and this is significant in relation to transplantation of the kidney, survival of a homotransplant is facilitated if the recipient is uremic. In consequence human renal transplants have been observed to function for several weeks, and in one instance for 176 days (Hume et al. 1955) , in patients not subjected to any special treatment. Even more striking results have been obtained in patients given 400-600 rads whole body irradiation. In two of these, as Dr Tubiana has mentioned, the donor and recipient were non-identical twins, but Kuiss and his colleagues (Kuiss, Legrain, Mathe, Nedey et al. 1960 : Kuss, Legrain, Mathe & Nedey 1960 have reported one case in which a kidney transplanted from a girl to her non-twin brother continued to function until the patient died four months later from metastatic cancer, and another patient treated by Kiiss et al. (1961) , who received a kidney from her brother-in-law in June 1960, is still alive.
There have, unfortunately, been many failures, only some of which have so far been reported. They appear to have been due in the main either to death of the patient from infection or hemorrhage, or to rejection of the transplant.
The risk of infection can be reduced by main-taining the patient under conditions of the strictest possible asepsis, and if infection does occur the chance of retrieving the position will depend on whether specific antibiotic therapy is available and if so how promptly it is begun.
Haemorrhage is a grave danger if the patient becomes grossly thrombocytopenic, and it is therefore essential to give repeated transfusions of blood platelets or fresh blood. Since the blood will in general not come from the graft donor it is advisable to avoid including viable, leucocytes, and experiments are in progress (Davis, Nolan & Woodruff, unpublished data) to determine whether leucocytes can be destroyed without damaging platelets by irradiating the blood. It seems likely that the risk of graft rejection would be reduced if the dosage of irradiation could be increased, and the discovery that animals may recover after otherwise lethal irradiation if given transplants of hemopoietic tissue, by intravenous infusion or otherwise (Lorenz et al. 1951 , see Woodruff 1960 for review) suggests that better results might be obtained by giving larger doses of irradiation than in the cases so far described, followed by transplantation of bone marrow and also of a kidney from the same donor. Unfortunately, such a procedure involves very serious risks.
In the first place, while it has been shown that foreign marrow transplanted to heavily irradiated animals may survive indefinitely (in which event the animals are termed radiation chimeras), this has been reported only once in man (Beilby et al. 1960) and the development of chimerism may have been due partly to the fact that the patient was suffering from Hodgkin's disease and received an alkylating agent as well as irradiation.
Secondly, even if the transplantation of marrow does prevent or correct the severe marrow aplasia which would otherwise result from the irradiation it does little to protect the gut and other tissues.
Thirdly, unless the donor is an identical twin (in which case irradiation would be unnecessary) there is a danger that the recipient, after an initial period of recovery, will develop serious and possibly fatal secondary disease. The symptoms of this condition, which was first described by Barnes et al. (1956) , closely resemble those of runt disease (vide supra), and it is now clear that secondary disease, too, is due to some of the grafted cells, or their descendants, reacting immunologically against the recipient.
In mice the severity of secondary disease depends inter alia on the strain combinations employed, and the nature and number of the cells injected. The magnitude of the hazard after transplantation of bone marrow in man is still uncertain, but Mathe et al. (1960) have adduced evidence which suggests that it is considerable. Secondary disease would probably not occur if foetal haemopoietic tissue could be used instead of adult, but although foetal liver has been used in a number of human patients after irradiation, there is still no convincing evidence that it can provide adequate hemopoietic replacement.
If chimerism could safely be induced in patients it would clearly be a great step forward because it would be possible to refrain from hazarding the donor's kidney until this had been done.
Administration of cytotoxic drugs: Goodwin (personal communication) administered nitrogen mustard to a patient who had received a kidney transplant. The patient died five months later from respiratory infection, but the transplant was still functioning. Calne (1960 Calne ( , 1961 has succeeded in prolonging the survival of kidney transplants in dogs by administering an antimetabolite, 6-mercaptopurine, and this drug is also being tried clinically though so far no reports have been published.
Clearly both the alkylating agents and the antimetabolites involve dangers comparable to those of whole body irradiation. Whether any of these drugs, either alone or in combination with irradiation, can achieve the desired result without causing serious damage remains to be seen.
It is apparent that advance in the clinical field depends on progress in the laboratory, and in particular on an increase in our understanding of, and control over, the immunological processes concerned in homograft rejection. As Voisin (1958) has expressed it: 'C'est dans la domaine immunologique que se jouera, que se joue dej"a, la partie passionnante dontl 'enjeu est la possibilite de pratiquer des homotransplantations d'organes vitaux assures d'une survie definitive.' But if the immunologist has the major role, the radiotherapist and surgeon have an important contribution to make, for we can provide essential techniques unfarniliar to most biologists, and it is our task to apply in the clinic the discoveries of the laboratory.
The Problem ofStorage Attempts are being made to store whole kidneys by cooling, by continuous perfusion, or by a combination of these methods, but so far the period for which a kidney can be maintained in a satisfactory state for transplantation is a matter of hours.
Ethical and Legal Problems The Tissue Grafting Act will make it possible, under certain conditions, to obtain any type of tissue or organ from a cadaver for purposes of transplantation, and not merely cornea as hitherto. Unfortunately if a kidney is to be used as a transplant it must be obtained within minutes of death, and this is only occasionally possible.
In consequence one must still look to living volunteers, and this raises difficult ethical (and one suspects also legal) problems.
As far as the ethical situation is concerned, if the patient's only hope of survival lies in transplantation and he is lucky enough to have a healthy identical twin with two normal kidneys, it seems right to put the facts to the twin, and accept a graft if offered. In the absence of an identical twin the situation is much more difficult, because the prospects of success are small but not entirely negligible. Our colleagues in France and the United States have shown us how to face these agonizing decisions with compassion and with courage. In trying to follow their lead we may perhaps gain some comfort from the reflection that:
... diseases desperate grown By desperate appliance are reliev'd Or not at all.' (Hamlet, IV, iii.) 
